<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2024-5549</article-id><article-id custom-type="edn" pub-id-type="custom">UWCBEN</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-5549</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФАРКТ МИОКАРДА. ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MYOCARDIAL INFARCTION. ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Показатели клинического анализа крови и поражения коронарного русла в прогнозировании госпитальной летальности у больных острым инфарктом миокарда с подъемом сегмента ST после чрескожного коронарного вмешательства</article-title><trans-title-group xml:lang="en"><trans-title>Parameters of complete blood count and coronary lesions in predicting inhospital mortality in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9250-557X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гельцер</surname><given-names>Б. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Geltser</surname><given-names>B. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Борис Израилевич Гельцер — д. м. н., профессор, член-корр. РАН, Школа медицины, зам. директора по научной работе </p><p>Владивосток</p></bio><bio xml:lang="en"><p>School of Medicine, Deputy Director for Research</p><p>Vladivostok</p><p> </p></bio><email xlink:type="simple">boris.geltser@vvsu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4539-685X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шахгельдян</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shahgeldyan</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карина Иосифовна Шахгельдян — д. т. н., доцент, Школа медицины, зав. лабораторией анализа больших данных в медицине и здравоохранении; директор института информационных технологий </p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">carina.shahgeldyan@vvsu.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6722-2535</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Домжалов</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Domzhalov</surname><given-names>I. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игорь Геннадьевич Домжалов — аспирант департамента клинической медицины, Школа медицины; врач отделения реанимации и интенсивной терапии регионального сосудистого центра </p><p>Владивосток</p></bio><bio xml:lang="en"><p>Far Eastern Federal University. School of Medicine, PhD Student, Department of Clinical Medicine;  Primorsky Regional Clinical Hospital No. 1 doctor of the intensive care unit of the regional vascular center</p><p>Vladivostok</p></bio><email xlink:type="simple">igor@domzhalov.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-9106-0117</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куксин</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuksin</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никита Сергеевич Куксин — магистрант </p><p>Владивосток</p></bio><bio xml:lang="en"><p>Vladivostok</p></bio><email xlink:type="simple">nikita.kuksin@vvsu.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5830-1322</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котельников</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotelnikov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимир Николаевич Котельников — д. м. н., профессор, Школа медицины, профессор департамента клинической медицины </p><p>Владивосток</p></bio><bio xml:lang="en"><p>School of Medicine, Professor of the department of clinical medicine</p><p>Vladivostok</p></bio><email xlink:type="simple">671235@mail.ru</email><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Дальневосточный федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern Federal University.</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО Дальневосточный федеральный университет; &#13;
ФГБОУ ВО Владивостокский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern Federal University;&#13;
Vladivostok State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО Дальневосточный федеральный университет;   &#13;
ГБУЗ Приморская краевая клиническая больница № 1</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern Federal University&#13;
Primorsky Regional Clinical Hospital No. 1</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБОУ ВО Владивостокский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Vladivostok State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГАОУ ВО Дальневосточный федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far Eastern Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>07</day><month>10</month><year>2023</year></pub-date><volume>29</volume><issue>2</issue><fpage>5549</fpage><lpage>5549</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гельцер Б.И., Шахгельдян К.И., Домжалов И.Г., Куксин Н.С., Котельников В.Н., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Гельцер Б.И., Шахгельдян К.И., Домжалов И.Г., Куксин Н.С., Котельников В.Н.</copyright-holder><copyright-holder xml:lang="en">Geltser B.I., Shahgeldyan K.I., Domzhalov I.G., Kuksin N.S., Kotelnikov V.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/5549">https://russjcardiol.elpub.ru/jour/article/view/5549</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценка предиктивного потенциала показателей клинического анализа крови (КАК) и поражения коронарных артерий (КА) для прогнозирования госпитальной летальности (ГЛ) у больных инфарктом миокарда с подъемом сегмента ST (ИМпST) после чрескожного коронарного вмешательства (ЧКВ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Проведено одноцентровое когортное ретроспективное исследование по данным 4677 электронных историй болезни пациентов с ИМпST (3203 мужчины и 1474 женщины). Было выделено 2 группы лиц, первую из которых составили 318 (6,8%) больных, умерших в стационаре, вторую — 4359 (93,2%) — с благоприятным исходом. Степень влияния предикторов на конечную точку определяли методом Шепли.</p></sec><sec><title>Результаты</title><p>Результаты. Наилучшие метрики качества имела модель, структура которой помимо 7 факторов КАК включала показатели трехсосудистого поражения коронарного русла, ремоделирования ствола левой КА и ограничения коронарной перфузии после ЧКВ по шкале TIMI &lt;2 (AUC — 0,845, чувствительность — 0,78, специфичность — 0,786). Наибольший вклад в реализацию конечной точки был связан с уровнем гемоглобина, лейкоцитов, иммуновоспалительного индекса и нейтрофилов &gt;75,4%. Менее заметное влияние на ГЛ оказывали индикаторы состояния КА, а минимальное — тромбокрит &gt;0,22%, лимфоциты &lt;13,3% и скорость оседания эритроцитов.</p></sec><sec><title>Заключение</title><p>Заключение. Модель многофакторной логистической регрессии на основе комбинации показателей КАК и индикаторов, характеризующих состояние коронарного русла, обладает высокой прогностической точностью, что определяет перспективы ее дальнейшего использования в качестве одного из доступных инструментов рискометрии в клинической практике.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To evaluate the predictive potential of complete blood count (CBC) and coronary involvement parameters for predicting inhospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI).</p></sec><sec><title>Material and methods</title><p>Material and methods. This single-center cohort retrospective study was conducted using data from 4677 electronic medical records of patients with STEMI (3203 men and 1474 women). Two groups of people were identified: group 1 — 318 (6,8%) patients who died in hospital; group 2 — 4359 (93,2%) patients with a favorable outcome. The degree of influence of predictors on the end point was determined by the Shapley method.</p></sec><sec><title>Results</title><p>Results. The best quality metrics had a model with structure included, in addition to 7 CBC factors, indicators of three-vessel coronary involvement, left coronary artery remodeling and coronary perfusion after PCI with the TIMI score &lt;2 (AUC — 0,845, sensitivity — 0,78, specificity — 0,786) . The greatest contribution to the implementation of the end point was associated with the level of hemoglobin, white blood cells, immune-inflammatory index and neutrophils &gt;75,4%. Coronary artery parameters had a less noticeable effect on inhospital mortality, and the minimal effect was plateletcrit &gt;0,22%, lymphocytes &lt;13,3% and erythrocyte sedimentation rate.</p></sec><sec><title>Conclusion</title><p>Conclusion. This multivariate logistic regression model based on a combination of CBC indicators and indicators characterizing the coronary system has high predictive accuracy, which determines the prospects for its further use as one of the available risk assessment tools in clinical practice.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инфаркт миокарда</kwd><kwd>чрескожное коронарное вмешательство</kwd><kwd>летальность</kwd><kwd>интеллектуальный анализ данных</kwd><kwd>отбор предикторов</kwd><kwd>прогнозирование</kwd><kwd>клинический анализ крови</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocardial infarction</kwd><kwd>percutaneous coronary intervention</kwd><kwd>mortality</kwd><kwd>data mining</kwd><kwd>predictor selection</kwd><kwd>prediction</kwd><kwd>clinical blood analysis.</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">ДВФУ</funding-statement><funding-statement xml:lang="en">Far Eastern federal university.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. doi:10.1016/S0140-6736(20)30925-9.</mixed-citation><mixed-citation xml:lang="en">GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. doi:10.1016/S0140-6736(20)30925-9.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Алекян Б. Г., Ганюков В. И., Маношкина Е. М., Ганюков В. И. Реваскуляризация при инфаркте миокарда с подъемом сегмента ST в Российской Федерации. Эндоваскулярная хирургия. 2019;6(2):89-97. doi:10.24183/2409-4080-2019-6-2-89-97.</mixed-citation><mixed-citation xml:lang="en">Alekyan BG, Ganyukov VI, Manoshkina EM, Ganyukov VI. Revascularization in ST elevation myocardial infarction in the Russian Federation. Endovascular surgery. 2019;6(2):89-97. (In Russ.) Аdoi:10.24183/2409-4080-2019-6-2-89-97.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Циванюк М. М., Гельцер Б. И., Шахгельдян К. И. и др. Показатели клинического анализа крови, липидного спектра и их соотношений в прогнозировании обструктивного поражения коронарных артерий у больных с острым коронарным синдромом без подъема ST. Российский кардиологический журнал. 2022;27(8):5079. doi:10.15829/1560-4071-2022-5079. EDN ADACCL.</mixed-citation><mixed-citation xml:lang="en">Tsivanyuk MM, Geltser BI, Shakhgeldyan KI, et al. Indicators of clinical blood test, lipid spectrum and their ratios in predicting obstructive lesions of the coronary arteries in patients with acute coronary syndrome without ST elevation. Russian Journal of Cardiology. 2022;27(8):5079. (In Russ.) doi:10.15829/1560-4071-2022-5079. EDN ADACCL.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Чаулин А. М., Григорьева Ю. В., Павлова Т. В., Дупляков Д. В. Диагностическая ценность клинического анализа крови при сердечно-сосудистых заболеваниях. Российский кардиологический журнал. 2020;25(12):3923. doi:10.15829/1560-4071-2020-3923.</mixed-citation><mixed-citation xml:lang="en">Chaulin AM, Grigoryeva YuV, Pavlova TV, Duplyakov DV. Diagnostic value of a clinical blood test in cardiovascular diseases. Russian Journal of Cardiology. 2020;25(12):3923. (In Russ.) doi:10.15829/1560-4071-2020-3923.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dong G, Huang A, Liu L. Platelet-to-lymphocyte ratio and prognosis in STEMI: A meta-analysis. Eur J Clin Invest. 2021;51(3):e13386. doi:10.1111/eci.13386.</mixed-citation><mixed-citation xml:lang="en">Dong G, Huang A, Liu L. Platelet-to-lymphocyte ratio and prognosis in STEMI: A meta-analysis. Eur J Clin Invest. 2021;51(3):e13386. doi:10.1111/eci.13386.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ji Z, Liu G, Guo J, et al. The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients. Front Cardiovasc Med. 2021;8:706852. doi:10.3389/fcvm.2021.706852.</mixed-citation><mixed-citation xml:lang="en">Ji Z, Liu G, Guo J, et al. The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients. Front Cardiovasc Med. 2021;8:706852. doi:10.3389/fcvm.2021.706852.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Öcal L, Keskin M, Cerşit S, et al. Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2022;33(4):251-60. doi:10.1097/MCA.0000000000001117.</mixed-citation><mixed-citation xml:lang="en">Öcal L, Keskin M, Cerşit S, et al. Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2022;33(4):251-60. doi:10.1097/MCA.0000000000001117.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28(14):1709-16. doi:10.1093/eurheartj/ehm184.</mixed-citation><mixed-citation xml:lang="en">Sorajja P, Gersh BJ, Cox DA, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28(14):1709-16. doi:10.1093/eurheartj/ehm184.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Molnar C. Interpretable Machine Learning: A Guide for Making Black Box Models Explainable. Raleigh: Lulu Press, 2020. p. 320. ISBN: 978-0-244-76852-2.</mixed-citation><mixed-citation xml:lang="en">Molnar C. Interpretable Machine Learning: A Guide for Making Black Box Models Explainable. Raleigh: Lulu Press, 2020. p. 320. ISBN: 978-0-244-76852-2.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Xu N, Tang X-F, Yao Y, Yao X. Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction. Catheter Cardiovasc Interv. 2018;91:551-7.</mixed-citation><mixed-citation xml:lang="en">Xu N, Tang X-F, Yao Y, Yao X. Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction. Catheter Cardiovasc Interv. 2018;91:551-7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">van Blokland IV, Groot HE, Hendriks T, et al. Sex differences in leukocyte profile in ST-elevation myocardial infarction patients Sci Rep. 2020;10(1):6851. doi:10.1038/s41598-020-63185-3.</mixed-citation><mixed-citation xml:lang="en">van Blokland IV, Groot HE, Hendriks T, et al. Sex differences in leukocyte profile in ST-elevation myocardial infarction patients Sci Rep. 2020;10(1):6851. doi:10.1038/s41598-020-63185-3.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Petzold T, Zhang Z, Ballesteros I, Saleh I, et al. Neutrophil "plucking" on megakaryocytes drives platelet production and boosts cardiovascular disease. Immunity. 2022;55(12):2285-2299.e7. doi:10.1016/j.immuni2022.10.001.</mixed-citation><mixed-citation xml:lang="en">Petzold T, Zhang Z, Ballesteros I, Saleh I, et al. Neutrophil "plucking" on megakaryocytes drives platelet production and boosts cardiovascular disease. Immunity. 2022;55(12):2285-2299.e7. doi:10.1016/j.immuni2022.10.001.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zeren G, Avcı İİ, Şimşek B, et al. Post percutaneous coronary intervention hemoglobin levels predict in-hospital mortality in patients with STEMI treated with primary percutaneous coronary intervention. Anatol J Cardiol. 2021;25(9):623-9. doi:10.5152/AnatolJCardiol.2021.07282.</mixed-citation><mixed-citation xml:lang="en">Zeren G, Avcı İİ, Şimşek B, et al. Post percutaneous coronary intervention hemoglobin levels predict in-hospital mortality in patients with STEMI treated with primary percutaneous coronary intervention. Anatol J Cardiol. 2021;25(9):623-9. doi:10.5152/AnatolJCardiol.2021.07282.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dimitriu-Leen AC, Hermans MPJ, Veltman CE, et al. Prognosis of complete versus incomplete revascularization of patients with STEMI with multivessel coronary artery disease: an observational study. Open Heart. 2017;4:e000541. doi:10.1136/openhrt-2016-000541.</mixed-citation><mixed-citation xml:lang="en">Dimitriu-Leen AC, Hermans MPJ, Veltman CE, et al. Prognosis of complete versus incomplete revascularization of patients with STEMI with multivessel coronary artery disease: an observational study. Open Heart. 2017;4:e000541. doi:10.1136/openhrt-2016-000541.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Барбараш О. Л., Поликутина О. М., Тавлуева Е. В., Барбараш Н. А. Поражение ствола левой коронарной артерии: взгляд кардиолога. Креативная кардиология. 2015;9(2):5-20. doi:10.15275/kreatkard-2015.02.01.</mixed-citation><mixed-citation xml:lang="en">Barbarash OL, Polikutina OM, Tavlueva EV, Barbarash NA. Damage to the trunk of the left coronary artery: a cardiologist's point of view. Creative cardiology. 2015;9(2):5-20. (In Russ.). doi:10.15275/kreatkard-2015.02.01.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Deng L, Zhao X, Su X, et al. Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention. BMC Med Inform Decis Mak. 2022;22(1):109. doi:10.1186/s12911-022-01853-2.</mixed-citation><mixed-citation xml:lang="en">Deng L, Zhao X, Su X, et al. Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention. BMC Med Inform Decis Mak. 2022;22(1):109. doi:10.1186/s12911-022-01853-2.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Altun B, Turkon H, Tasolar H, et al. The relationship between high-sensitive troponin T, neutrophil lymphocyte ratio and SYNTAX Score. Scand J Clin Lab Invest. 2014;74(2):108-15. doi:10.3109/00365513-2013-860619.</mixed-citation><mixed-citation xml:lang="en">Altun B, Turkon H, Tasolar H, et al. The relationship between high-sensitive troponin T, neutrophil lymphocyte ratio and SYNTAX Score. Scand J Clin Lab Invest. 2014;74(2):108-15. doi:10.3109/00365513-2013-860619.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
